Polyendocrine metabolic ovarian syndrome linked to atherosclerotic heart disease risk

Polyendocrine metabolic ovarian syndrome was associated with increased risk for atherosclerotic cardiovascular disease events and the association was only partially mediated by the presence of baseline comorbidities, researchers reported.Polyendocrine metabolic ovarian syndrome (PMOS), the new proposed name for polycystic ovary syndrome (PCOS), may be an independent predictor of ASCVD events,